Close Menu

Books in a Library

p38

The Application Methods of MAPKs Signal Pathway Inhibitor SP600125 and SB203580 in Long-term In-vivo Experiments

Issue: 
Vol 67, Issue 2: 2018
DOI: 
10.7727/wimj.2015.487
Pages: 
98-104
Synopsis: 
The intravenous injection of mitogen-activated protein kinase inhibitors SP600125 and SB203580 for four weeks significantly reduced the phosphorylation levels of JNK and p38 in vivo.

ABSTRACT

Objective: To explore the application methods of MAPK signal pathway inhibitor SP600125 and SB203580’s long-term experiments in vivo.

Received: 
07 Sep, 2015
Accepted: 
30 Sep, 2015
Published: 
02 Jun, 2018
PDF Attachment: 
PDF icon wimj-iss2-2018_98_104.pdf
Journal Sections: 
Original Articles
Keywords: 
In-vivo
JNK
MAPKs
p38
SB203580
SP600125
Journal Authors: 
H Cai
Q Chen
Y Liu
H Xie
Q Lu
X Chen
e-Published: 15 Jan, 2016
Subscribe to RSS - p38

West Indian Medical Journal

Faculty of Medical Sciences,
The University of the West Indies,
Mona, Kingston 7
Tel: (876) 927-1214
Fax: (876) 927-1846
wimj@uwimona.edu.jm
Top of Page